HC Wainwright & Co. Downgrades Marinus Pharmaceuticals (LSE:0JYL)
Source: NASDAQ Stocks / 26 Oct 2024 11:01:56 America/New_York
Fintel reports that on October 25, 2024, HC Wainwright & Co. downgraded their outlook for Marinus Pharmaceuticals (LSE:0JYL) from Buy to Neutral.
https://www.nasdaq.com/articles/hc-wainwright-co-downgrades-marinus-pharmaceuticals-lse-0jyl